Suppr超能文献

应使用哪些术语来描述治疗癫痫发作障碍的药物?一份 ILAE 立场文件。

Which terms should be used to describe medications used in the treatment of seizure disorders? An ILAE position paper.

机构信息

Department of Medicine, The University of Melbourne (Austin Health), Heidelberg, Victoria, Australia.

Department of Neuroscience, Monash University, Melbourne, Victoria, Australia.

出版信息

Epilepsia. 2024 Mar;65(3):533-541. doi: 10.1111/epi.17877. Epub 2024 Jan 27.

Abstract

A variety of terms, such as "antiepileptic," "anticonvulsant," and "antiseizure" have been historically applied to medications for the treatment of seizure disorders. Terminology is important because using terms that do not accurately reflect the action of specific treatments may result in a misunderstanding of their effects and inappropriate use. The present International League Against Epilepsy (ILAE) position paper used a Delphi approach to develop recommendations on English-language terminology applicable to pharmacological agents currently approved for treating seizure disorders. There was consensus that these medications should be collectively named "antiseizure medications". This term accurately reflects their primarily symptomatic effect against seizures and reduces the possibility of health care practitioners, patients, or caregivers having undue expectations or an incorrect understanding of the real action of these medications. The term "antiseizure" to describe these agents does not exclude the possibility of beneficial effects on the course of the disease and comorbidities that result from the downstream effects of seizures, whenever these beneficial effects can be explained solely by the suppression of seizure activity. It is acknowledged that other treatments, mostly under development, can exert direct favorable actions on the underlying disease or its progression, by having "antiepileptogenic" or "disease-modifying" effects. A more-refined terminology to describe precisely these actions needs to be developed.

摘要

长期以来,用于治疗癫痫发作疾病的药物有多种术语,如“抗癫痫药”、“抗惊厥药”和“抗癫痫发作药”。术语很重要,因为使用不能准确反映特定治疗作用的术语可能会导致对其作用的误解和不恰当的使用。目前的国际抗癫痫联盟(ILAE)立场文件采用 Delphi 方法制定了适用于目前批准用于治疗癫痫发作疾病的药物的英文术语建议。专家们达成共识,这些药物应统称为“抗癫痫发作药物”。这个术语准确地反映了它们对癫痫发作的主要症状作用,并降低了医疗保健从业者、患者或护理人员对这些药物的实际作用产生不适当期望或误解的可能性。用“抗癫痫发作”来描述这些药物并不排除这些药物对疾病过程和由癫痫发作的下游效应引起的合并症产生有益影响的可能性,只要这些有益影响可以仅仅通过抑制癫痫发作活动来解释。人们承认,其他治疗方法,主要是正在开发中的治疗方法,可以通过具有“抗癫痫发作生成”或“疾病修饰”作用,对潜在疾病或其进展产生直接有利的作用。需要开发更精确的术语来准确描述这些作用。

相似文献

3
Approach to the Medical Treatment of Epilepsy.
Continuum (Minneap Minn). 2022 Apr 1;28(2):483-499. doi: 10.1212/CON.0000000000001081.
4
The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond.
CNS Drugs. 2021 Sep;35(9):935-963. doi: 10.1007/s40263-021-00827-8. Epub 2021 Jun 18.
9
Initiating antiepilepsy treatment: An update of expert consensus in Spain.
Epilepsy Behav. 2021 Jan;114(Pt A):107540. doi: 10.1016/j.yebeh.2020.107540. Epub 2020 Nov 24.
10
Capturing seizures in clinical trials of antiseizure medications for -DEE.
Epilepsia Open. 2021 Jan 29;6(1):38-44. doi: 10.1002/epi4.12466. eCollection 2021 Mar.

引用本文的文献

1
Rebound effect, discontinuation, and withdrawal syndromes associated with drugs used in psychiatric and neurological disorders.
Pharmacol Rep. 2025 Apr;77(2):303-314. doi: 10.1007/s43440-024-00689-z. Epub 2024 Dec 23.
2
Newer glucose-lowering drugs reduce the risk of late-onset seizure and epilepsy: A meta-analysis.
Epilepsia Open. 2024 Dec;9(6):2528-2536. doi: 10.1002/epi4.13091. Epub 2024 Nov 2.
3
Initial clinical evidence on biperiden as antiepileptogenic after traumatic brain injury-a randomized clinical trial.
Front Neurol. 2024 Aug 7;15:1443982. doi: 10.3389/fneur.2024.1443982. eCollection 2024.
4
Movement Termination of Slow-Wave Sleep-A Potential Biomarker?
Brain Sci. 2024 May 13;14(5):493. doi: 10.3390/brainsci14050493.
5
Lamotrigine add-on therapy for drug-resistant focal epilepsy.
Cochrane Database Syst Rev. 2023 Dec 11;12(12):CD001909. doi: 10.1002/14651858.CD001909.pub4.

本文引用的文献

2
Treatment of Psychogenic Nonepileptic Seizures.
Curr Neurol Neurosci Rep. 2022 Aug;22(8):467-474. doi: 10.1007/s11910-022-01209-3. Epub 2022 Jun 8.
3
Autoimmune-Associated Seizures.
Continuum (Minneap Minn). 2022 Apr 1;28(2):363-398. doi: 10.1212/CON.0000000000001079.
5
The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond.
CNS Drugs. 2021 Sep;35(9):935-963. doi: 10.1007/s40263-021-00827-8. Epub 2021 Jun 18.
7
Time to Start Calling Things by Their Own Names? The Case for Antiseizure Medicines.
Epilepsy Curr. 2020 Mar;20(2):69-72. doi: 10.1177/1535759720905516. Epub 2020 Feb 20.
8
Deciphering the concepts behind "Epileptic encephalopathy" and "Developmental and epileptic encephalopathy".
Eur J Paediatr Neurol. 2020 Jan;24:11-14. doi: 10.1016/j.ejpn.2019.12.023. Epub 2019 Dec 31.
9
The aetiology of psychogenic non-epileptic seizures: risk factors and comorbidities.
Epileptic Disord. 2019 Dec 1;21(6):529-547. doi: 10.1684/epd.2019.1107.
10
Antiepileptic drugs: evolution of our knowledge and changes in drug trials.
Epileptic Disord. 2019 Aug 1;21(4):319-329. doi: 10.1684/epd.2019.1083.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验